Israel - English - Ministry of Health

bioavenir ltd - ampicillin as sodium salt; sulbactam as sodium salt - powder for solution for injection - ampicillin as sodium salt 1000 mg; sulbactam as sodium salt 500 mg - sulbactam - antibiotic for the treatment of bacterial infections caused by susceptible beta-lactamase producing strains of microorganisms, in the following conditions: 1. skin and skin structure infections ;2. intra- abdominal infections ;3. gynecological infections .

Israel - English - Ministry of Health

bioavenir ltd, israel - ampicillin as sodium salt; sulbactam as sodium salt - powder for solution for injection - ampicillin as sodium salt 2000 mg; sulbactam as sodium salt 1000 mg - sulbactam - antibiotic for the treatment of bacterial infections caused by susceptible beta-lactamase producing strains of microorganisms, in the following conditions: 1. skin and skin structure infections ;2. intra- abdominal infections ;3. gynecological infections .

European Union - English - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - prostatic neoplasms - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent.pylclari is indicated for use with positron emission tomography (pet).

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - ipratropium bromide - aerosol, spray - 20 mcg/dose - ipratropium bromide 20 mcg/dose

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - bisacodyl - suppository - 5 mg - bisacodyl 5 mg

United States - English - NLM (National Library of Medicine)

athenex pharmaceutical division, llc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae, staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae, and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli , group b streptococci, and other gram-negative bacteria ( listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp ., penicillin g-susceptible staphylococci, and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of ampicillin when treating streptococcal endocarditis. urinary tract infections caused by sensitive strains of e. coli and proteus mirabilis. gastrointestinal infections caused by salmonella typhi (typhoid fever), other salmonella spp., and shigella spp. (dysentery) usually respond to oral or intravenous therapy. bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed. therapy may be instituted prior to obtaining results of susceptibility testing. it is advisable to reserve the parenteral form of this drug for moderately severe and severe infections and for patients who are unable to take the oral forms. a change to oral ampicillin may be made as soon as appropriate. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin for injection, usp and other antibacterial drugs, ampicillin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. indicated surgical procedures should be performed. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

United States - English - NLM (National Library of Medicine)

athenex pharmaceutical division, llc. - nafcillin sodium (unii: 49g3001bck) (nafcillin - unii:4cnz27m7rv) - nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug (see clinical pharmacology - susceptibility test methods ). nafcillin should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to a methicillin-resistant staphylococcus spp., therapy with nafcillin for injection, usp should be discontinued and alternative therapy provided. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nafcillin for injection, usp and other antibacterial drugs, nafcillin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. a history of a hypersensitivity (anaphylactic) reaction to any penicillin is a contraindication.

United States - English - NLM (National Library of Medicine)

civica, inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae, staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae, and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli , group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis) . the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci, and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness o

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ampicillin - solution for injection - 250mg, 500mg, 1000mg - active: ampicillin

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amoxicillin trihydrate - capsule - 250mg, 500mg - active: amoxicillin trihydrate